Cancer Treatment: New, Improved...And Economic Exploitation?

A few years ago there was concern that poor people did not have access to the best health care because of high cost, but two new papers find that spending is actually too high. The first study examines recent trends in spending and use of oral cancer drugs. They find that average spending on the 47 available oral oncolytics — cancer medication taken specifically by mouth — increased from $940 million in the first quarter of 2006 to $1.4 billion by the third quarter of 2011.  read more

Read the whole article on

More from